MedPath

Effectiveness of Thoothuvalai nei in the management of Swasakaasam ( Bronchial asthma)

Phase 3
Conditions
Health Condition 1: J452- Mild intermittent asthma
Registration Number
CTRI/2023/09/057541
Lead Sponsor
ational Institute Of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age between 18to60 years

Sex Male Female and Transgender

Patients with clinical symptoms of Wheezing

Cough with or without expectoration

Dyspnea

Tightness of chest

Wheezing minimum 2 episodes per

week Any 2 or more symptoms will be

included

Patient who are willing to undergo Pulmonary function test

FEV1 50to80 will be taken

Patients who are willing to undergo radiological investigations and provide blood sample for lab investigation

Exclusion Criteria

Restrictive Lung disease

Tuberculosis

Emphysema

Pleural effusion

Pneumothorax

Cardiac diseases

Renal diseases

Pregnancy and Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is assessed by comparing the lung volumes & capacities in pre & post <br/ ><br>treatment using pulmonary function test reports <br/ ><br>Timepoint: 2 MONTHS - SCREENING <br/ ><br>2 MONTHS - PATIENT ENROLLMENT <br/ ><br>2 MONTHS - OUTCOME ASSESSMENT <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Changes in the clinical symptoms by Asthma control Questionaire <br/ ><br> Changes in laboratory parameters of IgE, AEC, ESR before & after treatment.Timepoint: 2 MONTHS - SCREENING <br/ ><br>2 MONTHS - PATIENT ENROLLMENT <br/ ><br>2 MONTHS - OUTCOME ASSESSMENT <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath